Is Rallybio Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Rallybio Corp (RLYB) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Rallybio Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Rallybio Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Rallybio Corp?

Muslim investors may consider investing in Rallybio Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Rallybio Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Rallybio Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Rallybio Corp updated?

The Shariah compliance status of Rallybio Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Rallybio Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Rallybio Corp?

You can check the latest Shariah compliance status of Rallybio Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

RLYB Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 18, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Rallybio Corp (RLYB)

Based on 10 analysts giving stock ratings to Rallybio Corp in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Rallybio Corp. Stock Analysis RLYB

United States Health Care Micro Cap Report: 2025 Annual

Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. The company is headquartered in New Haven, Connecticut and currently employs 14 full-time employees. The company went IPO on 2021-07-29. The company has a pipeline of product candidates aimed at addressing diseases with unmet medical need in the areas of complement dysregulation and hematology. The Company’s lead program, RLYB116, is a differentiated C5 inhibitor with the potential to treat diseases of complement dysregulation, with an initial focus on immune platelet transfusion refractoriness (PTR) and refractory antiphospholipid syndrome (APS). RLYB116 is a novel, once-weekly, small volume, subcutaneously injected C5 inhibitor designed to meet patient demand for a convenient, self-administered at-home solution. Its pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload. Its RLYB114 is a pegylated C5 inhibitor in development for complement-mediated ophthalmic disorders.

Key Statistics of Rallybio Corp (RLYB)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$13.80$14.50

Today's Open

$14.16

Volume

53.62K

P/E Ratio (TTM)

52 Week Range

$2.16$15.31

Market Cap

75.54M

Avg. Volume

560.66K

Dividend Yield

Financial Metrics & Statements of Rallybio Corp (RLYB)

FAQ's for Rallybio Corp (RLYB)

According to Musaffa’s Shariah screening methodology, Rallybio Corp (RLYB) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.